Headaches associated with GLP-1 therapy are typically most common during the initial weeks of treatment or following dose escalation
We plan to expand availability across Leeds and to our York clinic in the near future
Heerspink HJL, Stefnsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, et al
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management: A randomised, controlled, phase 1b trial
MOTS-C essentially mimics one of the protective signals that estrogen used to help maintain
[8] Receptors for IGF-1 are found in vascular smooth muscle, while typical receptors for insulin are not found in vascular smooth muscle